Skip to main content
Equibles
CDIO logo

CDIO · Cardio Diagnostics Holdings, Inc. · Documents

Track CDIO — free

Use CDIO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CDIO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.87 -0.05 (-2.60%) At close · Nov 12
Rebalance outlook locked
Market Cap
$5.53M
Shares
2.96M
Volume · Nov 12 26.37K Avg daily vol (3M) 31.3K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

Annual report FY2025 Revenue $14.83K down 57.5% 10-K filed Mar 13, 2026 Quarterly report New FY2026 Q3 Revenue $3590 up 25.7% 10-Q filed Nov 6, 2026
2026
Nov 6
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Revenue rose while net loss widened

Cardio Diagnostics Holdings reported three-month revenue of $3,590 for 2026 versus $2,855 for 2025, but net loss increased to $1,732,331 from $1,714,536. It expects to rely primarily on the ongoing ATM Offering for the remainder of 2026 if market conditions are favorable.

Revenue $3590 ▲ 25.7% Net loss $1.73M Diluted EPS -$0.59
Read from the MD&A section
4 source passages
Unless the context requires otherwise, references to “Cardio,” the “Company,” “we,” “us” and “our” refer to Cardio Diagnostics Holdings, Inc., a Delaware corporation, together with its consolidated subsidiary. Cardio had $3,590 and $2,855 in revenue for the three months ended September 30, 2026 and 2025, respectively. Cardio’s net loss for the three months ended September 30, 2026 was $1,732,331 as compared to $1,714,536 for the three months ended September 30, 2025, an increase of $17,795. We expect that for the remainder of 2026, we will rely primarily on the ongoing ATM Offering, provided that market conditions are favorable. Open the document at this passage
Aug 7
Quarterly report 10-Q FY2026 Q2, ended Jun 30
Quarterly report for FY2026 Q2 AI summary on its way
Revenue $5360 ▼ 28.3% Net loss $1.5M Diluted EPS -$0.51
Aug 5
Proxy statement DEF 14A Meeting Sep 18, 2026
Proxy statement AI summary on its way
Jul 13
Proxy statement PRE 14A Meeting Sep 18, 2026
Proxy statement AI summary on its way
May 15
Quarterly report 10-Q FY2026 Q1, ended Mar 31
Quarterly report for FY2026 Q1 AI summary on its way
Revenue $2680 ▲ 185.1% Net loss $1.79M Diluted EPS -$0.63
Mar 13
Annual report 10-K FY2025, ended Dec 31
Annual report for FY2025 AI summary on its way
Revenue $14.83K ▼ 57.5% Net loss $6.5M Diluted EPS -$3.71
2025
Mar 20
Annual report 10-K FY2024, ended Dec 31
Annual report for FY2024
Revenue $34.89K ▲ 104.5% Net loss $8.38M Diluted EPS -$0.31
2024
Apr 1
Annual report 10-K FY2023, ended Dec 31
Annual report for FY2023
Revenue $17.07K ▲ 1696.3% Net loss $8.38M Diluted EPS -$0.66
2023
Showing 1–50 of 93 documents
Key facts CIK 1870144 CUSIP 14159C202 13F (30d) 7 filings 7 filers Visit website Investor relations